AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome.
about
Botulinum Toxin A for Bladder Pain Syndrome/Interstitial CystitisManaging chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidenceCurrent guidelines in the management of interstitial cystitisComplementary and alternative medical therapies for interstitial cystitis: an update from the United StatesThe Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndromeInterstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapyIntravesical liposome drug delivery and IC/BPSClinical presentation and treatment of bladder pain syndrome/interstitial cystitis (BPS/IC) in IndiaInterstitial cystitis/painful bladder syndrome: the influence of modern diagnostic criteria on epidemiology and on Internet search activity by the publicThe enigma of men with interstitial cystitis/bladder pain syndromeRecommendations to the primary care practitioners and the patients for managing pelvic pain, especially in painful bladder syndrome for early and better prognosisFrom bladder to systemic syndrome: concept and treatment evolution of interstitial cystitisA healthy bladder: a consensus statementPentosan polysulfate: a novel therapy for the mucopolysaccharidosesDose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatmentPathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of DiseaseNovel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA InjectionA synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced diseaseEffects of interstitial cystitis on the acoustic startle reflex in cats.Quality of information on the internet related to bladder pain syndrome: a systematic review of the evidence.Treatment costs of bladder pain syndrome/interstitial cystitis in Austria: a pharmacoeconomic approach following current guidelines.Efficacy of intravesical chondroitin sulphate in treatment of interstitial cystitis/bladder pain syndrome (IC/BPS): Individual patient data (IPD) meta-analytical approach.Therapeutic effect of urine-derived stem cells for protamine/lipopolysaccharide-induced interstitial cystitis in a rat model.Changes in symptoms during urologic chronic pelvic pain syndrome symptom flares: findings from one site of the MAPP Research Network.Urothelial Tight Junction Barrier Dysfunction Sensitizes Bladder AfferentsSegmental hyperalgesia to mechanical stimulus in interstitial cystitis/bladder pain syndrome: evidence of central sensitizationBladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.Treatment of interstitial cystitis/painful bladder syndrome as a neuropathic pain condition.Altered detrusor gap junction communications induce storage symptoms in bladder inflammation: a mouse cyclophosphamide-induced model of cystitis.Bladder pain syndrome: validation of simple tests for diagnosis in women with chronic pelvic pain: BRaVADO study protocol.Metabolomics insights into pathophysiological mechanisms of interstitial cystitis.Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndromeUrological chronic pelvic pain syndrome symptom flares: characterisation of the full range of flares at two sites in the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.Amitriptyline: interstitial cystitis (painful bladder syndrome)Nerve stimulation for chronic pelvic pain and bladder pain syndrome: a systematic review.Urinary metabolite profiling combined with computational analysis predicts interstitial cystitis-associated candidate biomarkersCorrelation between psychological stress levels and the severity of overactive bladder symptomsThe overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis.Antiproliferative factor signaling and interstitial cystitis/painful bladder syndrome
P2860
Q26744717-D59D48A8-66D4-410C-B5BF-7D39A0176022Q26749098-309C97D5-A4F7-48AA-B7F7-C17440D31FE4Q26773527-6C19A847-3179-424D-B158-10FA21A597F7Q26773530-7C9C2CF7-EA42-4AFF-B871-D1CB92C1475BQ26773534-59EBD407-5366-4B9F-994E-8CBBA69B9615Q26773545-15E1685E-914A-4C85-8B89-96656097AAF6Q26773571-FB736A3E-A117-4C9B-B4DD-FB92947F586EQ26773590-7E43A8A4-B44F-4ECA-9A10-B2EA69E05356Q26773596-7579F78F-4245-4CF4-9C89-47ADB07A0865Q26774274-2E8F569F-4842-4124-9724-4DB938DFD314Q26780290-28FA9019-E0F2-47AA-809B-AD3B8FF496A7Q26801107-8E2293FA-9848-4913-80CE-1026606AE94AQ26863299-45BD646C-C714-40BA-B7B7-1D7818D28685Q27319509-82338D45-BC24-4425-AFD4-FF1455AC4AF9Q27321536-5757BD38-12A3-46A0-A09B-B5A655519113Q28079052-3456A394-7C3D-42BD-A663-3459E8237DB9Q28087509-C8D3C277-09D3-4494-BC82-ADB67EE9C2ABQ28485503-5D413B1D-4573-43FF-9735-E31EB6630169Q28534235-D02A585D-852D-41A2-AEEC-EDA316BB3135Q30414171-8BB51FEB-5B9E-4F74-BC8F-53C74BF6F236Q30486101-E147AD72-DE32-4BB1-B923-0CA98748A9A1Q30486310-8205AF33-94FF-4086-AF4B-695A62D53AA9Q30653372-4923ED53-B352-4A62-BA80-115021A99041Q33651101-50B8973D-C3D2-4776-ACF3-38F9F732527FQ33655364-62C207DC-C8D7-4C5E-B194-1AB0E2FE48A4Q33721298-8F05EDCB-773E-4E36-9699-5A51D65FA19FQ33806392-E651E8EF-5181-449C-A9B5-BB95421EA3C9Q33870858-C96C4B09-D33F-4A3F-A1D6-FE0F78B4DB8DQ33995485-84C2D55A-BEE7-431E-A799-6AB859B2F00BQ34010976-6694B827-854D-4B95-9F4B-73E8906E215EQ34248686-AF5995A2-442B-463F-8622-13C24F62A51AQ34267480-D80FCD7D-D80B-4FC2-8D6F-90A361ED83C6Q34267531-A89836B1-048D-4FCA-BF1F-847D779CE34AQ34345534-817853E4-F36A-4ADC-AFCD-8CD0198B456CQ34612769-38A27BFD-A16C-4643-A78B-EB140F4D3F1BQ34741755-7659A499-F9D8-43D6-B073-CCF4E0A41324Q34855915-7D54DCA1-8A56-4BDB-8A4B-8DEBF0615786Q35170051-76BFE756-DB1D-48CE-B812-272CDE1CF648Q35569758-048EF08F-9EAB-49CD-94A7-BD60ECD6DE0FQ35667287-F6C3D38A-1118-40A4-8629-BDAC42482722
P2860
AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
AUA guideline for the diagnosi ...... ystitis/bladder pain syndrome.
@en
AUA guideline for the diagnosi ...... ystitis/bladder pain syndrome.
@nl
type
label
AUA guideline for the diagnosi ...... ystitis/bladder pain syndrome.
@en
AUA guideline for the diagnosi ...... ystitis/bladder pain syndrome.
@nl
prefLabel
AUA guideline for the diagnosi ...... ystitis/bladder pain syndrome.
@en
AUA guideline for the diagnosi ...... ystitis/bladder pain syndrome.
@nl
P2093
P1476
AUA guideline for the diagnosi ...... ystitis/bladder pain syndrome.
@en
P2093
Barbara Gordon
Christopher K Payne
David Allen Burks
Deborah Erickson
Diane Newman
Interstitial Cystitis Guidelin ...... on Education and Research, Inc
J Quentin Clemens
John B Forrest
Leroy Nyberg
Martha M Faraday
P304
P356
10.1016/J.JURO.2011.03.064
P407
P577
2011-04-16T00:00:00Z